BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24458953)

  • 1. Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study.
    Mani V; Woodward M; Samber D; Bucerius J; Tawakol A; Kallend D; Rudd JH; Abt M; Fayad ZA
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):571-82. PubMed ID: 24458953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Fayad ZA; Mani V; Woodward M; Kallend D; Bansilal S; Pozza J; Burgess T; Fuster V; Rudd JH; Tawakol A; Farkouh ME
    Am Heart J; 2011 Aug; 162(2):214-221.e2. PubMed ID: 21835280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.
    Fayad ZA; Mani V; Woodward M; Kallend D; Abt M; Burgess T; Fuster V; Ballantyne CM; Stein EA; Tardif JC; Rudd JH; Farkouh ME; Tawakol A;
    Lancet; 2011 Oct; 378(9802):1547-59. PubMed ID: 21908036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
    Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
    Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
    J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata.
    Taqueti VR; Di Carli MF; Jerosch-Herold M; Sukhova GK; Murthy VL; Folco EJ; Kwong RY; Ozaki CK; Belkin M; Nahrendorf M; Weissleder R; Libby P
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):920-9. PubMed ID: 25170063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.
    Bucerius J; Duivenvoorden R; Mani V; Moncrieff C; Rudd JH; Calcagno C; Machac J; Fuster V; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2011 Nov; 4(11):1195-205. PubMed ID: 22093271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation.
    Oh M; Lee CW; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Moon DH; Park SW; Park SJ
    Clin Cardiol; 2019 Feb; 42(2):241-246. PubMed ID: 30537083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.
    Calcagno C; Ramachandran S; Izquierdo-Garcia D; Mani V; Millon A; Rosenbaum D; Tawakol A; Woodward M; Bucerius J; Moshier E; Godbold J; Kallend D; Farkouh ME; Fuster V; Rudd JH; Fayad ZA
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1884-93. PubMed ID: 23942908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
    Tawakol A; Fayad ZA; Mogg R; Alon A; Klimas MT; Dansky H; Subramanian SS; Abdelbaky A; Rudd JH; Farkouh ME; Nunes IO; Beals CR; Shankar SS
    J Am Coll Cardiol; 2013 Sep; 62(10):909-17. PubMed ID: 23727083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
    Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
    J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.
    Oh M; Lee CW; Lee HS; Chang M; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Moon DH; Park SW; Park SJ
    Clin Cardiol; 2016 Nov; 39(11):646-652. PubMed ID: 27459273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation.
    Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee CW
    BMC Cardiovasc Disord; 2019 Aug; 19(1):201. PubMed ID: 31426749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
    Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
    J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M; Tahara N; Tahara A; Nitta Y; Kodama N; Oba T; Mawatari K; Yasukawa H; Kaida H; Ishibashi M; Hayabuchi N; Harada H; Ikeda H; Yamagishi S; Imaizumi T
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1110-8. PubMed ID: 21999871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.